Related Experiment Video
Updated: Feb 18, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Dendrimers for Ocular Drug Delivery.
Michael G Lancina1, Hu Yang2,3,4
1Department of Biomedical Engineering, Virginia Commonwealth University, Richmond, VA 23284, United States.
Dendrimers, a type of nanoparticle, offer improved safety and efficiency for ocular drug delivery. These nanomedicine vehicles can be modified to target specific eye structures, overcoming limitations of current methods.
Area of Science:
- Ophthalmology
- Nanomedicine
- Polymer Chemistry
Background:
- Current ocular drug delivery methods face challenges with safety and efficacy.
- Nanomedicine offers potential solutions for controlled drug biodistribution in the eye.
Purpose of the Study:
- To review recent advancements in using dendrimers for ocular drug delivery.
- To highlight dendrimer modifications for targeting specific ocular structures.
Main Methods:
- Literature review of studies employing dendrimers for ocular drug delivery.
- Analysis of dendrimer modifications and their impact on targeting efficiency.
Main Results:
- Dendrimer-based nanomedicine shows promise for enhanced ocular drug delivery.
- Specific dendrimer modifications facilitate targeting of various ocular tissues.
Conclusions:
- Dendrimers represent a viable nanomedicine platform for improving ocular drug administration.
- Further research into dendrimer modifications can optimize targeted ocular therapies.
Related Concept Videos
Ophthalmic Drug Delivery Systems
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Drug Delivery Systems: Different Types
Modified-Release Drug Delivery Systems: Site-Targeted
Modified-Release Drug Delivery Systems: Stimuli-Activated

